Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)

NCT05092984 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Spironolactone
DRUG: Placebo

Sponsor

University Hospital, Strasbourg, France